Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
Date:7/28/2011

SEATTLE, July 28, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (NASDAQ and MTA: CTIC) today reported advancements in its efforts to develop its late stage oncology pipeline to market coupled with improved financial results for the second quarter ended June 30, 2011.

"In the second quarter, we seized on the momentum and the feedback provided by the FDA's Office of New Drugs ("OND") in allowing us to resubmit the pixantrone New Drug Application ("NDA") based on the PIX 301 data without requiring the Company to conduct additional clinical trials in advance of potential accelerated approval. Our type A meeting with the FDA's Division of Oncology Drug Products ("DODP") provided guidance on items in the Complete Response Letter and we are on track to provide this information, as well as the information OND requested, in the fourth quarter of 2011," said James A. Bianco, M.D., Chief Executive Officer of the Company. "With a six month review process after resubmission, approval of pixantrone in the United States may occur as early as April 2012.  Similarly, our meeting in April with representatives of the European Medicines Agency ("EMA") and our Marketing Authorization Application ("MAA") co-rapporteurs provided guidance for responding to the Day 120 letter that could allow a recommendation for approval before year end."

"In addition to these significant developments in advancing pixantrone to market, encouraging phase II tosedostat results, which were reported at ASCO, suggest a target population for a phase II/III registration-directed trial, which we expect to get underway in the first half of 2012 following an FDA meeting that we will request later this year. With OPAXIO advancing to its interim survival analysis in the phase III front-line maintenance ovarian cancer study and brostallicin generating excitement in the Mayo Clinic's North Central Cancer Treatment Groups' triple negative breast cancer study, 2012 can be a p
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
2. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
3. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
4. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
5. Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
6. Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
7. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
8. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
9. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
10. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
11. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 The consumer marketing playbook ... industry sectors to better identify winning tools and ... engage with and understand consumers, as new technologies ... critical purchasing decisions. According to ... one area where organizations can observe a deep ...
(Date:7/11/2014)... , July 11, 2014  Kindred Hospital ... to announce the opening of its new outpatient ... outpatient services to people with chronic, hard to ... which can lead to amputation, lower leg wounds ... have delayed closure, and traumatic injury wounds which ...
(Date:7/11/2014)... LOUIS , July 11, 2014 /PRNewswire/ ... device company, announced today the positive, cost-effective ... its innovative SPiNPerc™ procedure. The SPiNPerc endobronchial ... of a percutaneous approach to biopsy when ... Hospitals, patients and physicians experience positive financial ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Veran Medical Publishes Lung Cancer Patient Management Study 2
... ... , ATLANTA, Georgia, November 30 ... managed in partnership by MC Strategies/Elsevier and the, University of Minnesota,s ... on "Cerebral Palsy" is now,available for administrators and learners to use as ...
... 30 Middle-aged men and women who engage in high ... their knees and increasing their risk for osteoarthritis, according to ... Radiological Society of North America (RSNA). , "Our data suggest ... greater risk for developing knee abnormalities and, thus, at higher ...
Cached Medicine Technology:Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Too Much Physical Activity May Lead to Arthritis 2Too Much Physical Activity May Lead to Arthritis 3
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... & Peripheral Vascular Devices Market by ... Drug-Eluting), Catheter (IVUS, OCT), IVC Filter ... to 2018" analyzes and studies the ... in the U.S. and Canada. , ...
(Date:7/12/2014)... New York, New York (PRWEB) July 12, 2014 ... involving liver damage allegations continue to move forward ... District Court, Eastern District of Pennsylvania, Bernstein Liebhard ... 1, 2014, U.S. District Judge Lawrence F. Stengel ... president. Among other things, Judge Stengel found that ...
(Date:7/12/2014)... Sean Francis, owner of the Kawartha Lakes Fit ... his clients. He’s also known for his support of local non-profits ... to combine the two and is excited to announce that his ... and Girls Club. , The funds are the result of Francis’ ... Francis sent out emails and asked his clients to put out ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 For those who ... bodies can readily absorb the nutrients in food. The enzymes ... that are small enough to be absorbed by human bodies. ... a lack of enzymes in regular food is the cause ... product that was started by Michelle DelPresto, a mother of ...
(Date:7/12/2014)... 2014 Utah Valley Entrepreneurial Forum Top ... awards being bestowed to companies in revenue, and pre-revenue ... community with recognition for new ideas as well as ... revenue. , 25 Under 5 highlights outstanding Utah entrepreneurs ... under 5 years old. Award recipients were recognized at ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
... defend title as 238 runners with 33 corporate teams compete ... speed, size, and spirit categories this Sunday, ... Valley Marathon(R) announced today that the field for the third,annual ... 33 corporate teams competing. (Logo: http://www.newscom.com/cgi-bin/prnh/20010807/CMALOGO ) ...
... For millions of Americans the benefits,of aspirin go ... "low dose" aspirin can help prevent one out ... many people on aspirin therapy who take other ... to this report from Bayer at:, http://media.medialink.com/WebNR.aspx?story=34050 ...
... Nov. 2 /PRNewswire-FirstCall/ - The Westaim Corporation,announced today the ... credit line of $12.6 million from a major financial ... and will be secured by the,equivalent value of asset-backed ... announced that it held $19.7 million in ABCP. In,September, ...
... Consumer Behavior Is Focus of,Presentation at Association of ... NEW YORK, Nov. 2 Using,knowledge from neurosciences ... consumers, brains to gauge their response to commercials ... at Lapiz,says there are dangers in looking for ...
... YORK, Nov. 2 Recent outbreaks of,antibiotic-resistant Staphylococcus aureus, more ... A bacteria that healthy people,can carry on the skin or ... cause infections of the skin, in the blood, in the ... a wide range of antibiotics.,While most of these infections are ...
... (Amex: PTN ) today announced that it will ... Healthcare Conference at the New York Palace,Hotel in New ... ET. Carl Spana, Ph.D., President and Chief Executive ... Company,s corporate and,development programs. To access the live audio ...
Cached Medicine News:Health News:Biggest Field Ever to Compete Nov. 4 for 'Fastest Company in Silicon Valley' Title in the Comerica Corporate Challenge at The 2007 Metro Silicon Valley Marathon(R) 2Health News:Biggest Field Ever to Compete Nov. 4 for 'Fastest Company in Silicon Valley' Title in the Comerica Corporate Challenge at The 2007 Metro Silicon Valley Marathon(R) 3Health News:The Westaim Corporation update on status of short-term investments 2Health News:Exploring the Use of Techniques From Neuroscience in Today's Marketing 2Health News:Exploring the Use of Techniques From Neuroscience in Today's Marketing 3
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps angled ends size 3.5"....
Forceps, extra delicate, straight....
Jewelers Forceps, delicate, straight....
Medicine Products: